Starting triple oral hypoglycemic agent therapy in poorly controlled type 2 diabetes is a suitable therapeutic strategy to lower HbA1c when insulin therapy is not desired
2021 ◽
Vol 7
(1)
◽
Keyword(s):
A clinical decision report using: Søfteland E, Meier JJ, Vangen B, Toorawa R, Maldonado-Lutomirsky M, Broedl UC. Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial. Diabetes Care. 2016;40(2):201-209. https://doi.org/10.2337/dc16-1347 for a patient with uncontrolled type 2 diabetes on metformin and sitagliptin and hesitant to begin insulin therapy.
2016 ◽
Vol 7
(4)
◽
pp. 565-573
◽
Keyword(s):
2004 ◽
Vol 26
(5)
◽
pp. 680-693
◽
2008 ◽
Vol 30
(6)
◽
pp. 1081-1088
◽
2015 ◽
Vol 7
(1)
◽
pp. 76-84
◽
Keyword(s):
2007 ◽
Vol 29
(11)
◽
pp. 2374-2384
◽
2005 ◽
Vol 27
(5)
◽
pp. 554-567
◽
Keyword(s):